Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Guggenheim analyst Brad Canino downgraded Nuvalent, Inc (NASDAQ:NUVL) from Buy to Neutral and lowered the price target from $151 to $124. Nuvalent shares closed at $123.25 on Tuesday. See how other analysts view this stock.
  • UBS analyst David Dai downgraded Nuvalent, Inc (NASDAQ:NUVL) from Buy to Neutral and cut the price target from $138 to $124. Nuvalent shares closed at $123.25 on Tuesday. See how other analysts view this stock.
  • Wedbush analyst David Nierengarten downgraded Nuvalent, Inc (NASDAQ:NUVL) from Outperform to Neutral and cut the price target from $125 to $124. Nuvalent shares closed at $123.25 on Tuesday. See how other analysts view this stock.
  • Barclays analyst Etzer Darout downgraded Nuvalent, Inc (NASDAQ:NUVL) from Overweight to Equal-Weight and slashed the price target from $152 to $124. Nuvalent shares closed at $123.25 on Tuesday. See how other analysts view this stock.
  • RBC Capital analyst Piral Dadhania downgraded NIKE, Inc. (NYSE:NKE) from Outperform to Sector Perform and lowered the price target from $70 to $50. Nike shares closed at $44.65 on Tuesday. See how other analysts view this stock.

Considering buying NUVL stock? Here’s what analysts think:

Photo via Shutterstock